1. Home
  2. FR vs IBRX Comparison

FR vs IBRX Comparison

Compare FR & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Industrial Realty Trust Inc.

FR

First Industrial Realty Trust Inc.

HOLD

Current Price

$66.54

Market Cap

8.9B

Sector

Real Estate

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.04

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FR
IBRX
Founded
1993
2014
Country
United States
United States
Employees
152
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
7.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
FR
IBRX
Price
$66.54
$7.04
Analyst Decision
Buy
Strong Buy
Analyst Count
12
7
Target Price
$62.17
$12.57
AVG Volume (30 Days)
1.3M
10.0M
Earning Date
04-22-2026
05-08-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
38.71
EPS
1.66
N/A
Revenue
$727,076,000.00
$113,288,000.00
Revenue This Year
$11.27
$88.59
Revenue Next Year
$7.19
$131.15
P/E Ratio
$40.04
N/A
Revenue Growth
8.58
668.31
52 Week Low
$47.38
$1.95
52 Week High
$69.88
$12.43

Technical Indicators

Market Signals
Indicator
FR
IBRX
Relative Strength Index (RSI) 56.15 38.87
Support Level $59.98 $6.69
Resistance Level $69.88 $8.54
Average True Range (ATR) 1.41 0.47
MACD -0.00 -0.15
Stochastic Oscillator 42.96 4.99

Price Performance

Historical Comparison
FR
IBRX

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: